Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.

Published

Journal Article

Clinical management of infective endocarditis (IE) is expected to become more difficult with the emergence of Staphylococcus aureus with reduced susceptibility to vancomycin (SARV) in the United States and worldwide. We report the strain characterization and treatment of a patient with SARV IE.

Full Text

Duke Authors

Cited Authors

  • Woods, CW; Cheng, AC; Fowler, VG; Moorefield, M; Frederick, J; Sakoulas, G; Meka, VG; Tenover, FC; Zwadyk, P; Wilson, KH

Published Date

  • April 15, 2004

Published In

Volume / Issue

  • 38 / 8

Start / End Page

  • 1188 - 1191

PubMed ID

  • 15095227

Pubmed Central ID

  • 15095227

Electronic International Standard Serial Number (EISSN)

  • 1537-6591

Digital Object Identifier (DOI)

  • 10.1086/383027

Language

  • eng

Conference Location

  • United States